Literature DB >> 7922946

Use of blood donation history of people with HIV infection to identify recipients at risk.

M J Gill1, G Meyers, A Rajwani.   

Abstract

OBJECTIVE: To determine whether previous blood donations from HIV-positive patients posed a threat to recipients.
DESIGN: Interviewer-administered questionnaire survey.
SETTING: Regional HIV outpatient referral clinic for southern Alberta. PATIENTS: All 478 patients attending the clinic from May 1, 1993, to Mar. 31, 1994; 366 were excluded: 335 had not donated blood, and 31 could not provide reliable information regarding possible donations.
INTERVENTIONS: Patients were asked at a routine clinic visit regarding the dates, frequency and location of previous blood donations. The Canadian Red Cross was informed, with patient consent, if the previous donations posed a potential risk of HIV transmission. OUTCOME MEASURES: Number of HIV-positive patients whose donations posed a possible or definite risk to recipients.
RESULTS: A total of 545 units of blood had been donated by the 112 patients in the study; 57 units (donated by 29 patients) posed a possible risk, and 12 (given by 11 patients) posed a definite risk of HIV transmission to the recipients. Thirty-two of these donors had been unknown to the Red Cross through its "look-back" and "trace-back" protocols. Only 1 of the 13 patients found to be HIV positive by the Red Cross openly admitted donating blood to undergo HIV antibody testing; the remainder were either ill-informed or did not perceive themselves to be at risk. The patients were highly mobile, 36.7% donating blood at some time in a province other than the one where they had received their positive HIV test result.
CONCLUSION: Asking HIV-positive patients about their blood donation history, although subject to recall bias, is a simple and inexpensive method for identifying high-risk blood donations. The Red Cross should routinely be notified, with patient consent, of all donations posing a risk in order to enhance the prospect for identifying HIV-positive blood recipients.

Entities:  

Mesh:

Year:  1994        PMID: 7922946      PMCID: PMC1337233     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

1.  Traceback of a case of acquired immune deficiency syndrome related to a blood transfusion.

Authors:  S L Allaire
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

2.  "Look back" program for blood product recipients: experience with the pediatric population in Houston, Texas.

Authors:  S E Denson; W K Hoots; L K Pickering; A W Bracey; R R Reves; M V Gresik; J S Werch
Journal:  Pediatr Infect Dis J       Date:  1988-08       Impact factor: 2.129

3.  Look back: the status of recipients of blood from donors subsequently found to have antibody to HIV.

Authors:  R M Kakaiya; R G Cable; J Keltonic
Journal:  JAMA       Date:  1987-03-06       Impact factor: 56.272

4.  Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations.

Authors:  E Donegan; M Stuart; J C Niland; H S Sacks; S P Azen; S L Dietrich; C Faucett; M A Fletcher; S H Kleinman; E A Operskalski
Journal:  Ann Intern Med       Date:  1990-11-15       Impact factor: 25.391

5.  Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.

Authors:  A R Lifson; S P Buchbinder; H W Sheppard; A C Mawle; J C Wilber; M Stanley; C E Hart; N A Hessol; S D Holmberg
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

6.  Effect of CD4+ cell count measurement variability on staging HIV-1 infection.

Authors:  D R Hoover; N M Graham; B Chen; J M Taylor; J Phair; S Y Zhou; A Muñoz
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

7.  The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.

Authors:  J W Ward; T J Bush; H A Perkins; L E Lieb; J R Allen; D Goldfinger; S M Samson; S H Pepkowitz; L P Fernando; P V Holland
Journal:  N Engl J Med       Date:  1989-10-05       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.